Key result
The Rem distal C-terminus and G-domain mediate alpha1C-binding-dependent inhibition of CaV1.2 channels by interacting with different partners than in beta-binding-dependent inhibition.
The study identifies that the distal C-terminus and G-domain of Rem are repurposed to initiate two independent mechanisms of CaV1.2 channel inhibition, advancing the understanding of RGK protein function.
Extends molecular models of CaV1.2 regulation; leaves open whether these interactions affect cardiac function or therapies.
Rad/Rem/Rem2/Gem (RGK) proteins are Ras-like GTPases that potently inhibit all high-voltage-gated calcium (CaV1/CaV2) channels and are, thus, well-positioned to tune diverse physiological processes. Understanding how RGK proteins inhibit CaV channels is important for perspectives on their (patho)physiological roles and could advance their development and use as genetically-encoded CaV channel blockers. We previously reported that Rem can block surface CaV1.2 channels in 2 independent ways that engage distinct components of the channel complex: (1) by binding auxiliary β subunits (β-binding-dependent inhibition, or BBD); and (2) by binding the pore-forming α1C subunit N-terminus (α1C-binding-dependent inhibition, or ABD). By contrast, Gem uses only the BBD mechanism to block CaV1.2. Rem molecular determinants required for BBD CaV1.2 inhibition are the distal C-terminus and the guanine nucleotide binding G-domain which interact with the plasma membrane and CaVβ, respectively. However, Rem determinants for ABD CaV1.2 inhibition are unknown. Here, combining fluorescence resonance energy transfer, electrophysiology, systematic truncations, and Rem/Gem chimeras we found that the same Rem distal C-terminus and G-domain also mediate ABD CaV1.2 inhibition, but with different interaction partners. Rem distal C-terminus interacts with α1C N-terminus to anchor the G-domain which likely interacts with an as-yet-unidentified site. In contrast to some previous studies, neither the C-terminus of Rem nor Gem was sufficient to inhibit CaV1/CaV2 channels. The results reveal that similar molecular determinants on Rem are repurposed to initiate 2 independent mechanisms of CaV1.2 inhibition.
No takes yet. Share an insight, caveat, or question.
Puckerin et al. (2016) studied this question. Rem protein was evaluated on Molecular determinants for ABD CaV1.2 inhibition. The Rem distal C-terminus and G-domain mediate alpha1C-binding-dependent inhibition of CaV1.2 channels by interacting with different partners than in beta-binding-dependent inhibition.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: